Please login to the form below

Not currently logged in
Email:
Password:

Brazil

This page shows the latest Brazil news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Italy in turmoil, Pharma attacks Europe's generics move and more

Daily Brief: Italy in turmoil, Pharma attacks Europe's generics move and more

The company will acquire rights to Seroquel and Seroquel XR in 51 countries and regions including China, the UK, Brazil, Australia, Saudi Arabia, Mexico, South Korea, Thailand, Argentina, Malaysia and other

Latest news

More from news
Approximately 11 fully matching, plus 232 partially matching documents found.

Latest Intelligence

  • Creating a successful global compliance programme Creating a successful global compliance programme

    Additionally, Brazil’s Clean Companies Act applies strict liability regarding interactions with public officials, and South Korea’s Kim Young-ran Act has adopted a broader definition of public officials that

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    Brazil and India all seeking to attract global investment, at the same time as the UK seeks to break away from the EU market.

  • Risky business for pharma Risky business for pharma

    Risky business for pharma. China, Russia and Brazil are expected to provide the most issues. ... Across all sectors, the UK tied with Brazil for second place as the “market.

  • The ‘Million Hour Challenge’ The ‘Million Hour Challenge’

    For example, as part of ‘World Simplification Day’, simplification champions in AstraZeneca Brazil launched a ‘Waste Hunter’s Contest’ - an initiative built on lean principles. ... who likely would not have connected, actually come together to

  • The focus of global healthcare communication The focus of global healthcare communication

    Today, Vietnam, Russia and Brazil are equally as important as Spain or Germany to our clients.

More from intelligence
Approximately 7 fully matching, plus 40 partially matching documents found.

Latest appointments

  • IFPMA elects Pfizer’s Ian Read as president IFPMA elects Pfizer’s Ian Read as president

    He subsequently held a number of increasingly senior operational positions across Pfizer's Latin America business, including country manager for Pfizer Brazil and chief financial officer for Pfizer Mexico, before becoming

  • Ferring's Inna Demidova moves to ELC Ferring's Inna Demidova moves to ELC

    ELC plans to open its Moscow office later this year and is eyeing further expansion in Brazil and China soon.

  • Takeda promotes Giles Platford Takeda promotes Giles Platford

    Prior to this he was general manager of Takeda Brazil, leading the acquisition of Multilab, a mid-sized company focused on branded generics and over-the-counter (OTC) products. ... The acquisition made Takeda one of the top 10 pharmaceutical groups

  • Daniel Sterzi joins Kantar Health Spain Daniel Sterzi joins Kantar Health Spain

    Prior to this, he worked for GFK Customer Research France and Vivo (Telefónica Brazil), where he began his career as a marketing analyst.

  • Boehringer's Wolfram Carius to step down Boehringer's Wolfram Carius to step down

    He will leave Boehringer on June 30 as managing director responsible for biopharmaceuticals and production, after a career that included spells in Japan and Brazil. “

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • Webinar: The Brazil Conundrum

    Webinar: The Brazil Conundrum. Conducting research in one of the world's largest pharma markets. ... Brazil is predicted to be the 6th largest pharmaceutical market in the world by 2014.

  • Nutrition Market in Brazil: Growth Against the Odds

    Nutrition Market in Brazil: Growth Against the Odds. Published in eyeforpharma June 2017 by Marc Yates. ... Until the recession of 2014, Brazil saw a sustained period of strong growth in the functional foods and nutritional supplements market, albeit

  • 5 years on from the Brazilian Generics Drugs Act, is there still an opportunity for branded originator drugs?

    However, 5 years on from the act, the three categories of medication in Brazil remain: “ originator” or “ reference” drugs, “ generic” drugs, and “ similares”. ... In fact the term “ similares” in Brazil is typically used

  • Competition from within

    Teva (Israel), CSL (Australia) and Aspen (South Africa) are notable exceptions, with the Indian generic giants Sun and Ranbaxy - which have since merged - the only representation from the ‘ BRIC’ markets (Brazil, ... In this article, I will explore

  • Infographic: LATAM

    Infographic: LATAM. Latin America. The LATAM regions largest markets of Argentina, Brazil, Chile, Colombia, Mexico and Venezuela, is home to more than 460 million people and is a key global growth

More from PMHub
Approximately 3 fully matching, plus 36 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics